Brokerages Set Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Target Price at $109.70
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) has been assigned an average rating of “Hold” from the twelve ratings firms that are covering the stock, Marketbeat reports. Ten investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among […]
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) has been assigned an average rating of “Hold” from the twelve ratings firms that are covering the stock, Marketbeat reports. Ten investment analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price objective among […]
